The Second Xiangya Hospital, Central South University — Changsha, Hunan

Public research footprint of The Second Xiangya Hospital, Central South University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Major Depressive Disorder · Lung Cancer · Latent Autoimmune Diabetes in Adults (LADA) · Refractory Acute Lymphoblastic Leukemia

Recently updated registry entries

NCT07317934 — Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related… (Recruiting)
NCT05129904 — Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients… (Active Not Recruiting)
NCT06378177 — A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Second Xiangya Hospital, Central South University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.